VivoSeq
Neurology

PARKINSON DISEASE (disorder)

3

Pipeline Programs↗

9

Active Trials↗

1

Companies Involved↗

PARKINSON DISEASE (Disorder) is an early-stage landscape with 3 programs across 1 company. The most active players are Eli Lilly. 1 program is in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

Phase 1

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Mf-1

University of Shizuoka

Phase 21

AB-1005

AskBio Inc

Phase 31

Best Oral Medication

University Hospital Tuebingen

Approved
No programs

Analysis

Trial Status

11

clinical trials

Recruiting5 · 45%
Not yet recruiting4 · 36%
Completed2 · 18%

Clinical Trials

Trial Activity

11 trials

Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Recruiting·UUniversity Hospital Tuebingen·Phase 3·NCT07151378·150 enrolled
Protocol for a Superiority Randomized Controlled Trial of a Group-Based Fatigue Management Program Versus Standard Information to Improve Self-Efficacy in Energy Conservation in Parkinson's Disease
Recruiting·UUniversita degli Studi di Genova·Preclinical·NCT07094269·80 enrolled
Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application
Recruiting·FFujian Medical University Union Hospital·N/A·NCT07679256·700 enrolled
A Phase I Investigator-initiated First-in-human Study to Evaluate the Safety and Pharmacokinetics of MF1 in Healthy Adults and Patients With Parkinson's Disease (MF1-FIH)
Recruiting·UUniversity of Shizuoka·Phase 1·NCT07666022·58 enrolled
Effects of Tai Chi Therapy Versus Qi-Gong on Postural Control, Functional Balance , and Motor Function in Stage-I Parkinson's Patients.
Recruiting·Lahore University of Biological and Applied Sciences·Preclinical·NCT07662837·50 enrolled
"SwallowFit," an Exercise Program and Randomized Clinical Trial Designed for US Service Members, Veterans, and Families Affected by Parkinson's Disease.
Not yet recruiting·TThe University of Texas Health Science Center at San Antonio·Preclinical·NCT07356414·80 enrolled
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
Not yet recruiting·The University of Texas at Dallas·Preclinical·NCT07534397·20 enrolled
Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)
Not yet recruiting·AAskBio Inc·Phase 2·NCT07215403·18 enrolled
Effects of Cognitive-Based Balance Rehabilitation on Balance, Gait and Cognitive Functions in Parkinson's Disease Patients: Comparison of Virtual Reality and Dual Task
Not yet recruiting·BBezmialem Vakif University·Preclinical·NCT07660978·34 enrolled
Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
Completed·BBezmialem Vakif University·N/A·NCT07148700·40 enrolled
Vibrotactile Stimulation for Parkinson's Disease
Completed·UUniversity of Colorado, Denver·Phase 1·NCT07687732·12 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)